Zomedica Corp. (AMEX:ZOM) saw an upside of 3.32% to close Monday at $0.22 after adding $0.01 on the day. The 5-day average trading volume is 4,026,780 shares of the company’s common stock. It has gained $0.2200 in the past week and touched a new high 2 times within the past 5 days. An average of 4,805,830 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,232,216.
ZOM’s 1-month performance is 6.34% or $0.0130 on its low of $0.1990 reached on 07/20/23. The company’s shares have touched a 52-week low of $0.15 and high of $0.41, with the stock’s rally to the 52-week high happening on 01/18/23. YTD, ZOM has achieved 33.74% or $0.0550 and has reached a new high 6 times. However, the current price is down -46.83% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
ZOM stock has a beta of 0.96. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 10.08 while the price-to-book (PB) in the most recent quarter is 0.81.
Zomedica Corp.’s quick ratio for the period ended March 30 was 14.80, with the current ratio over the same period at 15.10. In terms of profitability, the gross margin trailing 12 months is 71.30%. The firm’s gross profit as reported stood at $13.65 million against revenue of $18.93 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 38.34% to -$6.39 million, while revenue of -$2.81 million was 56.03% off the previous quarter. Analysts expected ZOM to announce $0 per share in earnings in its latest quarter, but it posted -$0.01. EBITDA for the quarter stood at more than -$6.8 million. ZOM stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 16.54 million, with total debt at $1.58 million. Shareholders hold equity totaling $979.95 million.
Let’s look briefly at Zomedica Corp. (ZOM) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 58.97% to suggest the stock is trending Neutral, with historical volatility in this time period at 33.55%.
The stock’s 5-day moving average is $0.2122, reflecting a +3.81% or $0.0080 change from its current price. ZOM is currently trading +3.81% above its 20-day SMA, -10.29% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +9.66% and SMA200 by+3.51%.
Stochastic %K and %D was 46.35% and 39.35% and the average true range (ATR) pointed at 0.0106. The RSI (14) points at 56.20%, while the 14-day stochastic is at 73.08% with the period’s ATR at 0.0106. The stock’s 9-day MACD Oscillator is pointing at 0.0017 and 0.0029 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Zomedica Corp. (AMEX: ZOM), Dawson James launched coverage with a Buy rating.
